BASF Offers Cash for Norwegian Drug Maker

BASF SE, the world’s biggest chemical maker, agreed to pay 4.85 billion Norwegian kroner ($842 million) for Norway’s Pronova BioPharma ASA to expand in fatty acids used in health foods.
Sharp’s Default Risk Jumps Most Since 2012
30:05 - Sharp’s bond risk has jumped the most since 2012 as the prospects of a state-backed rescue fade. Last week, the cost to insure debt in the Japanese display maker rose to the highest level for any Asian tech company. Bloomberg’s Pavel Alpeyev reports on “Trending Business.” (Source: Bloomberg)
  • Former CEO of PT Berau Refuses to Leave His Office
  • The Top Stocks to Watch in Asia Today
  • Japanese Market Is Showing Signs of Life: Dagan